Drug
Idalopirdine clinical trials
Also written Lu AE58054.
- studies test it
- 14
- open now
- 0
- in phase 3
- 4
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
14 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 2
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses idalopirdine is read from its arms, and is right about nine times in ten.
Testing it · 14
- Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseCompletedPhase 3H. Lundbeck A/SNCT02079246Written as Idalopirdine 60 mg
- Positron Emission Tomography (PET) Study in Patients With Alzheimer's DiseaseTerminatedPhase 1H. Lundbeck A/SNCT03307993Written as Idalopirdine
- Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilCompletedPhase 3H. Lundbeck A/SNCT02006641Written as Idalopirdine
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorCompletedPhase 3H. Lundbeck A/SNCT02006654Written as Idalopirdine
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With DonepezilCompletedPhase 3H. Lundbeck A/SNCT01955161Written as Idalopirdine
- Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With SchizophreniaCompletedPhase 2H. Lundbeck A/SNCT00810667Written as Lu AE58054
- Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney FunctionCompletedPhase 1H. Lundbeck A/SNCT02340195Written as Idalopirdine (Lu AE58054) 60 mg
- Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy MenCompletedPhase 1H. Lundbeck A/SNCT02436486Written as Idalopirdine 360 mg
- Investigating the Absorption, Metabolism and Excretion (AME) of IdalopirdineCompletedPhase 1H. Lundbeck A/SNCT02415907Written as [ethyl-1-14C]-idalopirdine
- Bioequivalence Study of Idalopirdine Tablets 60 mgCompletedPhase 1H. Lundbeck A/SNCT02371707Written as Idalopirdine 60 mg formulation A (test)
- Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy SubjectsCompletedPhase 1H. Lundbeck A/SNCT02122692Written as Lu AE58054 30 mg
- Absolute Bioavailability of Lu AE58054 in Healthy SubjectsCompletedPhase 1H. Lundbeck A/SNCT02019394Written as Lu AE58054
- Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian SubjectsCompletedPhase 1H. Lundbeck A/SNCT01975779Written as Cohort B1: Lu AE58054
- Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's DiseaseCompletedPhase 2H. Lundbeck A/SNCT01019421Written as Lu AE58054
Codes
What other systems call idalopirdine · ClinicalTrials.gg INT005938
- UNII (FDA) 59WCJ0YNWMIDALOPIRDINEConfirmed FDA, Wikidata
- Wikidata Q855545idalopirdineConfirmed FDA, Wikidata
- NCI Thesaurus C166835IdalopirdineOne source FDA
- DrugBank DB11957One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 59WCJ0YNWM | IDALOPIRDINE | Confirmed FDA, Wikidata |
| Wikidata | Q855545 | idalopirdine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166835 | Idalopirdine | One source FDA |
| DrugBank | DB11957 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.